The clinical treatment strategy for Bismuth-Corlette type Ⅲ hilar cholangiocarcinoma / 中华普通外科杂志

ABSTRACT

Objective To evaluate the result of peri-hilar resection(extrahepatic bile duct resection plus local hepatectomy) and hepaticojejunostomy for the treatment of Bismuth-Corlette type Ⅲ hilar cholangiocarcinoma (HCCA).Methods This study was conducted on 37 patients divided into group A undergoing peri-hilar resection (extrahepatic bile duct resection combined with local hepatectomy) and hepaticojejunostomy (n =17) and group B treated by extrahepatic bile duct combined with hemihepatectomy and hemicaudatectomy and cholangioenterostomy (n =20).Results The incidence of postoperative acute liver failure was lower in group A than in group B (x2 =5,332,P =0.021).There was no significant difference in clinical data and survival rate (OS) between the two groups of patients and other complications.Conclusion For patients with Bismuth-Corlette type Ⅲ HCCA,the peri-hilar resection (extrahepatic bile duct combined with local hepatectomy)and hepaticojejunostomy reduces the incidence of postoperative acute liver failure.